Mark Clisby - President Senior roles in the public sector, universities and NGOs, CEO of two social enterprises Martin Wilkinson – Vice President Director of Clinical Studies for a not-for-profit healthcare company Andrew Bretherton – Secretary A banking lawyer with over 40 years experience Russell Smith – Treasurer Accountant and passionate supporter of not-for-profit organisations Rebecca Davey CEO, Arthritis ACT Caitlin Phillips-Peddlesden International development expert, Oxfam Australia, specialising in monitoring and evaluation

Jenny – Parliamentary Liaison Officer Carol – Data Management Maria – Information Line Jason - Communications Jen - General support Louise, Jolien, Sarah – Research Digest Jop – Storyteller Gretchen, Dave - Online Forum

Anne Wilson – Chief Executive Officer Dr Richard Schloeffel OAM – Medical Director Simone Eyssens – Research Director Amy Gibson – Operations Manager Laura Allen – Health & Support Services Manager, Telehealth Nurse Jessica Kauhausen, PhD – Biobank Coordinator (Maternity leave) Michelle Tavoletti, PhD - Research Manager Rochelle Lade, PhD – Education and Programs Manager Kate Herbert – Nurse Educator Laura Kool – Operations Officer Susan Sayer – Donor Relations Manager John Jeffries – Ambassador

Team

Check out the great people working behind the scenes at Emerge Australia.

Latest

Our GPs need to know what to do: We have the plan, we need the funds

Emerge Australia has written a 5 years plan for GP Education about ME/CFS, Long COVID and post-viral diseases, accessible to all of Australia’s GPs.
What will it take for Australia to get new clinical guidelines for ME/CFS?

$1,200,000 is required over 2 years for the development of national clinical guidelines for ME/CFS It is a matter of urgency for Australia to update its clinical guidelines for ME/CFS, to ensure Australian ME/CFS patients have access to the best possible care, based on current understanding of the condition and latest evidence.
Australians with ME/CFS need Optimal Care Pathways

$1,100,000 is required over 5 years for an Optimal Care Pathway for ME/CFS. Optimal Care Pathways (OCP) support integrated shared care across the entire health system. Such innovative approaches to the coordination of non-clinical service delivery have achieved improved outcomes for patients in other settings.
Changes to the Support and Services programs

With the completion of our Patient Pathways telehealth pilot program on June 30, 2022 we will be making some changes to how the service works and the programs it delivers.

	Anne Wilson – Chief Executive Officer
	Dr Richard Schloeffel OAM – Medical Director
	Simone Eyssens – Research Director
	Amy Gibson – Operations Manager
	Laura Allen – Health & Support Services Manager, Telehealth Nurse
	Jessica Kauhausen, PhD – Biobank Coordinator (Maternity leave)
	Michelle Tavoletti, PhD - Research Manager
	Rochelle Lade, PhD – Education and Programs Manager
	Kate Herbert – Nurse Educator
	Laura Kool – Operations Officer
	Susan Sayer – Donor Relations Manager
	John Jeffries – Ambassador

Team

Staff

Volunteers

Board